Inactive Instrument
Eidos Therapeutics, Inc. Stock
Stocks
EIDX
US28249H1041
Biotechnology & Medical Research
| 1 day | -4.85% |
| Manager | Title | Age | Since |
|---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 47 | 01/03/2016 |
Jonathan Fox
PSD | President | 69 | 01/10/2016 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/06/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan A. Barr
BRD | Director/Board Member | - | 26/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 26/01/21 | Issuer sale | Director | 25,973 | 0.0668% | ||
| 26/01/21 | Issuer sale | Director | 25,973 | 0.0668% | ||
| 26/01/21 | Tender | Director | 113,325 | 0.2916% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.85% | -4.63% | - | - | 4.75B | |
| +0.24% | -1.54% | +52.85% | +60.31% | 53.83B | |
| -7.17% | -4.39% | +42.72% | +73.32% | 52.1B | |
| +0.80% | -6.31% | +5.62% | +413.12% | 23.48B | |
| -0.09% | -0.01% | -16.85% | -16.17% | 23.13B | |
| -5.95% | -2.58% | +29.53% | -7.67% | 19.36B | |
| -1.14% | +0.03% | +31.67% | -31.21% | 17.56B | |
| -5.16% | -7.00% | +168.44% | +291.24% | 15.2B | |
| -6.91% | -5.83% | +25.17% | +636.97% | 14.83B | |
| +0.43% | -1.03% | +25.75% | +186.18% | 14.06B | |
| Average | -2.98% | -2.62% | +40.54% | +178.45% | 25.95B | |
| Weighted average by Cap. | -2.84% | -2.36% | +39.55% | +137.81% |
Employees
-
